Human Microbiome Market Insights and Global Outlook During 2021 to 2026 - Vedanta, Seres Therapeutics, Second Genome

Human Microbiome Market report provides the impact of novel COVID-19 pandemic on the market, as well as rise and fall during the forecast period. The research report delivers complete observation of various aspects, including the rate of growth, regional scope and recent developments by the primary market players. The report offers PESTEL, Porter’s Five Forces and market analysis to provide a 360-degree research study on the global Human Microbiome market. The research study provides data about important market strategies, future plans, market share growth, and product portfolios of leading companies.

The global Human Microbiome market will register a 22.5% CAGR in terms of revenue, and the market size will reach USD 564.6 million by 2025.

Top Companies in the global Human Microbiome market are
Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC, and Other.

Click here to get the free sample copy of Human Microbiome market before purchase:
https://www.marketinsightsreports.com/reports/02172611845/global-human-microbiome-market-growth-status-and-outlook-2021-2026/inquiry?Source=MW&Mode=72

The human microbiome is our “other genome.” Implicated in a growing list of complex diseases, for which genomic studies typically explain a portion of the disease susceptibility, the human gut microbiome has been at the spotlight for our understanding of human diseases.

Market News
- CAMBRIDGE / September 23, 2019 / Vedanta Biosciences Announces $16.6 Million Series C-2 Financing
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced a $16.6 million Series C-2 financing round, bringing the total capital raised in its Series C and C-2 round to $62.1 million.
For More Information Use Referral Links below

- BOSTON / March 21, 2018 / Symbiotix Biotherapies Announces License Agreement with Harvard University
Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering venture-backed microbiome company developing novel molecular therapeutics based on the human microbiome, today announced that it has entered into a license agreement with Harvard University.
For More Information Use Referral Links below

By type Human Microbiome market is divided into
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others

By application Human Microbiome market is divided into
Treatment
Diagnosis
Others

Browse full Human Microbiome market report description with TOC:
https://www.marketinsightsreports.com/reports/02172611845/global-human-microbiome-market-growth-status-and-outlook-2021-2026?Source=MW&Mode=72

Regional Analysis

Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), North America (United States, Canada, and Mexico), Central & South America (Brazil, and Rest of South America), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Important Features and Key Highlights of the Reports
– Comprehensive overview of Market
– Changing market dynamics of the industry
– Detailed market segmentation by Type, Application, etc.
– Past, present, and predictable market size in terms of volume and value
– Current industry trends and developments
– Competitive landscape of market
– Plans of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

Free customization of the report: This report can be further customized according to the client’s specific requirements. No additional charges will be added for limited additional research.

References
https://www.businesswire.com/news/home/20190922005062/en/Vedanta-Biosciences-Announces-16.6-Million-Series-C-2-Financing
https://www.businesswire.com/news/home/20180321005336/en/Symbiotix-Biotherapies-Announces-License-Agreement-with-Harvard-University

Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States

Contact US :
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.